Adalimumab 40 mg/0.8 ml PFS/Vial
STORES/WEST CENTRAL RLY · Pharmaceuticals · open
Key facts
- Published: 17 Jul 2026
- Closing date: 31 Aug 2026
- Status: open
Description
Tender for supply of Adalimumab 40 mg/0.8 ml PFS/Vial to various WCR units, with a closing date of 31/08/2026, including item details, delivery terms, and eligibility criteria.
Eligibility & requirements
- Startup relaxation: No
- MSE relaxation: No
New to these terms? Read how tender eligibility criteria work.
Commercial terms
- Bid type: Limited
- Evaluation: Itemwise/Consigneewise
- Make in India (MII): No
- MSE preference: No
Line items (3)
- Adalimumab 40 mg/0.8 ml PFS/Vial — Qty: 50 Numbers
- Adalimumab 40 mg/0.8 ml PFS/Vial — Qty: 16 Numbers
- INJ. ADALIMUMAB 40 MG/0.8 ML PFS — Qty: 107 Numbers
1 tender document(s) available — sign up to download.
Related tenders
- Torsemide 10 mg — Pharmaceuticals
- Bilastine 20 mg — Pharmaceuticals
- Paclitaxel 260 mg Injection — Pharmaceuticals · Madhya Pradesh
- TAB/CAP TEMOZOLAMIDE 100 MG. — Pharmaceuticals · Madhya Pradesh · ₹8.0L
- Megesterol 160 mg TABLETS — Pharmaceuticals · ₹10.0L
- Running Contract for Tab/Cap Azelnidipine 16 mg in strip packing. — Pharmaceuticals
- Running Contract for Sodium Chloride 3%, 100 ml Glass Bottle. — Pharmaceuticals
- Running Contract for Salbutamol 2.5 mg /2.5 ml Nebulising Solution 2.5 ml Respule/Amp. — Pharmaceuticals